A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
NCT05443191
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Semaglutide
Sponsor
Novo Nordisk A/S